Workflow
SINOMED(688108)
icon
Search documents
高位股下挫,联环药业等多股跌停
Ge Long Hui A P P· 2025-08-21 05:54
格隆汇8月21日|A股市场午后高位股持续下挫,联环药业、中电鑫龙、飞龙股份、金田股份跌停,申 联生物、赛诺医疗、济民健康(维权)、卧龙电驱、川润股份、汉钟精机、广生堂等均跌超8%。 MACD金叉信号形成,这些股涨势不错! ...
赛诺医疗获融资买入3.78亿元,近三日累计买入12.51亿元
Sou Hu Cai Jing· 2025-08-21 00:20
融券方面,当日融券卖出0.00万股,净卖出0.00万股。 来源:金融界 8月20日,沪深两融数据显示,赛诺医疗获融资买入额3.78亿元,居两市第51位,当日融资偿还额4.05亿 元,净卖出2651.39万元。 最近三个交易日,18日-20日,赛诺医疗分别获融资买入4.03亿元、4.70亿元、3.78亿元。 ...
严重异常波动股票(25.8.21)
Xuan Gu Bao· 2025-08-21 00:13
| 股票名称 | 监控开始日期 监控结束日期 异动开始日期 | | --- | --- | | *ST苏吴 | 2025-08-21 2025-09-03 未披露 | | 600200 | | | 赛诺医疗 | 2025-08-19 2025-09-01 2025-08-07 | | 688108 | | | 赛诺医疗 | 2025-08-18 2025-08-29 2025-08-07 | | 688108 | | | 东芯股份 | 2025-08-18 2025-08-29 2025-07-07 | | 688110 | | | 淳中科技 | 2025-08-15 2025-08-28 未披露 | | 603516 | | | 长城军工 | 2025-08-14 2025-08-27 2025-07-31 | | 601606 | | | 赛诺医疗 | 2025-08-14 2025-08-27 2025-08-07 | | 688108 | | | 东芯股份 | 2000 NO 00 NO ON NUMBER ON THE NOWN | *免责声明:文章内容仅供参考,不构成投资建议 *风险提示:股市有风 ...
政策引领医疗器械企业聚焦高端创新
Group 1 - The medical device sector has gained significant attention, with 125 out of 131 companies in the A-share market experiencing stock price increases in the past month, and Sino Medical Science Technology Co., Ltd. achieving a remarkable stock price increase of 207.59% [1] - Institutional investors are actively researching the medical device industry, indicating a reassessment of growth potential in this sector [1] - The Chinese government has introduced supportive policies to accelerate the high-quality development of the medical device industry, aiming to transition from a major pharmaceutical country to a strong one [1] Group 2 - In July, the National Medical Products Administration released measures to support innovation in high-end medical devices, including medical robots and AI medical devices, highlighting the government's focus on high-end innovation [2] - The high-end medical device market in China is projected to grow rapidly, with an estimated market size of 2.8 trillion yuan by 2030, driven by technological advancements and domestic replacements [2] - The push for high-end innovation is expected to break the "low-end lock-in" in the medical device industry, enhancing the overall value and international competitiveness of the sector [2] Group 3 - Companies like Maide Medical Industrial Equipment Co., Ltd. are expanding their overseas channels through exhibitions and customer visits, with overseas orders expected to exceed 60 million yuan by the end of 2024 [3] - Anjies Medical Technology Co., Ltd. is deepening its global layout through localized operations and overseas production bases, successfully selling products to over 60 countries [3] - The global demand for medical devices is increasing, particularly in emerging markets, providing significant opportunities for Chinese medical device companies to expand internationally [3]
8月逾70股涨幅超50%,这些强势股有何特征?
证券时报· 2025-08-20 12:44
Core Viewpoint - Since August, the A-share market has entered a new upward trend, with nearly 90% of stocks rising, indicating a broad-based rally [2][3][4]. Group 1: Market Performance - The Shanghai Composite Index has increased by 5.40%, the Shenzhen Component Index by 8.33%, the ChiNext Index by 12%, and the Sci-Tech 50 Index by 9.57% since August [3]. - Approximately 4,800 A-shares have risen since August, accounting for nearly 90% of all A-shares, with around 600 stocks increasing by over 20% [3]. - In comparison to July, where the Shanghai Composite Index rose by 3.74% and the Shenzhen Component Index by 5.20%, the performance in August has been stronger [3]. Group 2: Characteristics of Strong Stocks - Among the stocks that have risen over 50% since August, 32 are from the main board, 23 from the ChiNext, 13 from the Sci-Tech board, and 6 from the Beijing Stock Exchange [6]. - The mechanical equipment sector has the highest number of strong stocks, with 17, followed by the electronics sector with 11, and both the pharmaceutical and computer sectors with 8 each [6]. - More than half of the stocks with over 50% gains have a market capitalization of less than 10 billion yuan, indicating a predominance of small and mid-cap stocks [6]. Group 3: Company Performance - Many companies among the strong stocks have reported significant growth in revenue and net profit for the first half of 2025, with some companies like Tongzhou Electronics and Shuangyi Technology achieving over 100% growth in net profit [7].
8月20日科创板主力资金净流入7.30亿元
Sou Hu Cai Jing· 2025-08-20 10:15
沪深两市全天主力资金净流出302.29亿元,其中,科创板主力资金净流入7.30亿元,主力资金净流入的 有252只股,主力资金净流出的有335只股。 证券时报•数据宝统计显示,今日科创板个股上涨的有359只,涨停的有盛科通信、浩辰软件等2只,下 跌的有218只。 资金流向方面,今日主力资金净流入的科创板股共有252只,其中,15只个股主力资金净流入超亿元, 海光信息主力资金净流入10.84亿元,净流入资金居首;寒武纪、中芯国际紧随其后,全天净流入资金 分别为8.37亿元、3.85亿元。主力资金净流出的有335只,净流出资金最多的是东芯股份,该股今日下跌 3.75%,全天主力资金净流出3.66亿元,其次是赛诺医疗、壹石通,主力资金净流出分别为3.05亿元、 1.77亿元。 | 688468 | 科美诊断 | 166.76 | 2.68 | -0.23 | 1.77 | | --- | --- | --- | --- | --- | --- | | 688726 | 拉普拉斯 | 159.72 | 1.22 | 1.04 | 7.52 | | 688192 | 迪哲医药 | 152.10 | 0.53 | 0.76 ...
8月以来这些股票实现翻倍!沪指突破十年高点,市场爆炒方向有哪些?
Hua Xia Shi Bao· 2025-08-20 02:06
Market Overview - The A-share market has entered a new round of upward momentum since August, with the Shanghai Composite Index reaching a new high since December 2021 on August 13, and further breaking through 3700 points on August 14, eventually peaking at 3746.67 points on August 19 [2][3]. Market Performance - Over 4600 stocks have risen since August, with more than 80% of stocks showing gains. Approximately 240 companies have increased by over 30%, and around 70 companies have seen gains exceeding 50% [5]. - Six companies have doubled their stock prices in August, including Sainuo Medical (194.39%), Gebijia (152%), and Shunlian Bio (117.82%) [5][6]. Industry Performance - A total of 28 sectors have recorded monthly gains exceeding 10% in August, indicating strong market momentum. The Electric Machinery II sector led with a 21.33% increase, followed by the Motorcycle and Communication Equipment sectors with gains of 19.84% and 19.50%, respectively [8][9][10]. - Other notable sectors include Home Appliance Components II and Consumer Electronics, which rose by 18.63% and 18.11%, respectively [9][10]. Investment Insights - The continuous rise in margin trading balances, reaching 2.1 trillion yuan, has been a significant driver of the market's strength, accounting for 2.32% of the A-share market's circulating market value [4]. - Analysts suggest that the market's long-term sustainability relies on performance support, with a focus on high-quality companies and sectors poised for cyclical recovery and globalization [4][11].
赛诺医疗获融资买入4.70亿元,居两市第46位
Sou Hu Cai Jing· 2025-08-20 00:02
融券方面,当日融券卖出0.00万股,净卖出0.00万股。 来源:金融界 8月19日,沪深两融数据显示,赛诺医疗获融资买入额4.70亿元,居两市第46位,当日融资偿还额4.31亿 元,净买入3852.53万元。 最近三个交易日,15日-19日,赛诺医疗分别获融资买入3.45亿元、4.03亿元、4.70亿元。 ...
赛诺医疗收盘下跌2.56%,滚动市盈率2738.89倍,总市值168.17亿元
Sou Hu Cai Jing· 2025-08-19 11:47
8月19日,赛诺医疗今日收盘40.42元,下跌2.56%,滚动市盈率PE(当前股价与前四季度每股收益总和 的比值)达到2738.89倍,总市值168.17亿元。 来源:金融界 赛诺医疗科学技术股份有限公司的主营业务是高端介入医疗器械研发、生产、销售。公司的主要产品是 生物降解药物涂层冠脉支架系统、药物洗脱支架系统、非顺应性PTCA球囊扩张导管、PTCA球囊扩张 导管、非顺应性球囊扩张导管、冠脉球囊扩张导管、冠状动脉棘突球囊扩张导管、延长导管、颅内药物 洗脱支架系统、颅内取栓支架、颅内球囊扩张导管、负压吸引泵、一次性使用无菌吸引延长管、远端通 路导管、颅内血栓抽吸导管、微导管、远端通路导引导管、导引导管、桡动脉通路导引系统、输送导 管、球囊导引导管。 最新一期业绩显示,2025年一季报,公司实现营业收入1.01亿元,同比10.75%;净利润296.93万元,同 比277.50%,销售毛利率59.66%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13赛诺医疗2738.8911227.6219.32168.17亿行业平均 59.4955.005.10121.17亿行业中值40.1939.642.955 ...
高位股集体冲高回落
Mei Ri Jing Ji Xin Wen· 2025-08-19 02:40
每经AI快讯,高位股集体冲高回落,赛诺医疗回吐逾13%涨幅转跌,胜宏科技翻绿,中际旭创、新易盛 涨幅显著收窄,寒武纪突破千元关口后回落近4%。 (文章来源:每日经济新闻) ...